HC Wainwright Increases Travere Therapeutics (NASDAQ:TVTX) Price Target to $19.00

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its target price hoisted by equities research analysts at HC Wainwright from $17.00 to $19.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 248.62% from the stock’s […]

Related Keywords

Christopherr Cline ,Piper Sandler ,Schonfeld Strategic Advisors ,Travere Therapeutics Inc ,Jacobs Levy Equity Management Inc ,Securities Exchange Commission ,Sg Americas Securities ,Wells Fargo Company ,Vanguard Group Inc ,Travere Therapeutics Company Profile ,Jump Financial ,Travere Therapeutics ,Get Free Report ,Therapeutics Stock Down ,Exchange Commission ,Strategic Advisors ,Levy Equity Management ,Iga Nephropathy ,Travere Therapeutics Daily ,Nasdaq Tvtx ,Tvtx ,Medical ,Boost Price Target ,Hc Wainwright ,